We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates Hematology and Total Laboratory Automation Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Mindray (Shenzhen, China) is returning to ADLM after five years to unveil cutting-edge lab innovations and clinical insights. More...

At ADLM 2025, Mindray is highlighting the MT 8000 Intelligent TLA Solution designed for streamlined, automated laboratory operations. The MT 8000 Intelligent TLA Solution promises to revolutionize lab operations with unmatched flexibility and automation across five critical disciplines. Mindray is also highlighting the M6000 Laboratory Automation System that can empower ultra-high volume laboratories with high processing speed, less hands-on time, great cost efficiency, and standardized analytical quality.

Visitors to Mindray’s booth at ADLM 2025 can also experience its ALL IN ONE Hematology Solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation. It enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and a high demand for turnaround times.

The focus is also on the CAL 9000 New Generation Cellular Analysis Line that showcases Mindray's expertise and innovation for large-volume hematology laboratories. Mindray is also showcasing the M1000 chemistry and immunoassay integrated solution for large-scale laboratories alongside the M980 chemistry and immunoassay integrated solution for mid-scale laboratories.

Mindray is presenting the FA-N60 next-generation scalable blood culture system that features real-time blood volume monitoring, an intelligent satellite information transmission system, and newly designed culture bottles. It enables rapid diagnosis of bloodstream infections with an optimized workflow. In addition, visitors to the company’s booth can experience the CX-6000 Series next-generation mid-end automated coagulation analyzer that has been developed based on the CX-9000 Series platform.

Also being highlighted at ADLM 2025 is the Mindray EU 8600 (and EU 8600 GT) fully automated urinalysis system designed for high-throughput laboratories, featuring multi-depth-of-field fusion, vibration-proof system, 2K full-color clear imaging, and high analysis volume for sediment particles. In addition to presenting innovative breakthroughs,

Additionally, Mindray is also holding expert-led workshops shaping the future of laboratory diagnostics. This includes a workshop on hs-cTnI (high-sensitivity cardiac troponin I) and expert-led discussions on advancing myocardial injury management. Mindray’s focus on high-sensitivity cardiac troponin I clinical insights highlights important advances and ongoing challenges in myocardial injury management—an essential conversation for improving patient outcomes.

Related Links:
Mindray


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.